Alliance Healthcare UK: solus agreement with MSD UK and Organon UK

Following on from previous announcements confirming that, as of 1st February 2022, Alliance Healthcare UK will become with only wholesaler to supply both the MSD and Organon product portfolio to all pharmacies, hospitals and dispensing doctors in Great Britain and Norther Ireland, we can confirm that eligible lines in these two portfolios will have an applied discount of 7%.

If you have any queries, please speak to your Alliance Healthcare Account Manager.

Viatris UK Limited – Reduced Wholesale Agreement

Please read this communication carefully for information regarding an upcoming product ordering blackout period for Upjohn UK Ltd lines. Key details are:

• – Customers will be unable to order the Upjohn UK Ltd product portfolio between 24th-31st December 2021. 

• – Impacted products will be available for order from 1st January 2022 for delivery from 4th January 2022.

• – List of impacted products included below in Appendix 1.

From 1st January 2022, Alliance Healthcare UK will become one of the chosen wholesalers to supply the Viatris UK Limited (“Viatris”) product portfolio to all pharmacies, hospitals and dispensing doctors in the UK including Northern Ireland.

To view the full Viatris product portfolio please click here. 

With effect from 1st January 2022, the business of Upjohn UK Limited (“Upjohn”) will be transferred to Viatris (formerly Mylan UK Healthcare Limited), so that all UK Viatris commercial activities operate under a single legal trading entity. Upjohn will cease to trade from this date. As a result of this change customers will be unable to order the Upjohn product portfolio impacted by this blackout period between 24th-31st December 2021. All affected products are highlighted in the above product list.

Final orders for these products will be your standard cut-off time on the evening of Thursday 23rd December for AM delivery on the 24th December. Following the morning deliveries on 24th December 2021 Upjohn will cease Direct to Pharmacy sales and transition to a Reduced Wholesaler Model through Viatris. Customers will be able to place orders for the impacted lines with Alliance Healthcare from 1st January 2022 for delivery from 4th January 2022.

Viatris have recently shared their own communication on this change advising you to ensure you have stock available within your pharmacies to cover any demand of the impacted products until the end of December 2021. Please click here to view this communication. The purchase, supply and distribution of all other Viatris products will remain unchanged, and will continue to be available through their existing supply arrangements both through this transition and from 1st January 2022.

From 1st January 2022, purchases of these lines will arrive as part of your usual Alliance Healthcare delivery service and, if purchased in isolation they will be subject to Alliance Healthcare’s low spend surcharge.

To receive the products from 1st January 2022, you can simply order from Alliance Healthcare in your usual manner. These products will be available on a same day delivery service.

If you would like to discuss these changes in more detail, please do not hesitate to contact your Alliance Healthcare Account Manager.

Alliance Healthcare UK to enter into a solus wholesale agreement with Organon UK: 1st February 2022

We are pleased to announce that, as of 1st February 2022, Alliance Healthcare UK will become the only wholesaler to supply the Organon UK product portfolio to all pharmacies, hospitals and dispensing doctors in Great Britain and Northern Ireland.

The majority of the Organon UK portfolio has now been divested from MSD as of June 2021.

If you have any queries, please speak to your Alliance Healthcare Account Manager.

MSD – Solus Agreement

From 1st February 2022, Alliance Healthcare UK together with Alloga will become the only pre wholesaler / wholesaler partnership to supply the MSD portfolio to all pharmacies, hospitals and dispensing doctors in the United Kingdom and Northern Ireland. You can order these lines from Alliance Healthcare in your usual way.

If you have any queries, please speak to your Alliance Healthcare Account Manager.

Alliance Healthcare UK becomes one of four partner wholesalers in agreement with Sanofi UK 01 November 2021

We would like to inform you that Sanofi UK has chosen to partner with Alliance Healthcare UK to optimise supply of its products and services to the Independent Pharmacy sector.

Sanofi UK has now partnered with four national UK Pharmacy Wholesalers to supply all Sanofi UK consumer healthcare products to the Independent Pharmacy sector, hospitals, and other healthcare outlets.

As a partner wholesaler to Sanofi UK, we, Alliance Healthcare Ltd are delighted to continue to promote Sanofi UK products, offering support on ranging, merchandising, recommendation and key category insights via monthly promotional magazines and online platforms.

Sanofi UK will continue its support to Community Pharmacies via the Sanofi Field and Telesales teams using the following assets:

• - Transfer Orders
• - Point of Sale activation
• - Staff Training & Education Resources
• - Digital Assets
• - Seasonal Promotional Offers (via Wholesaler of their choice)

A further four product lines will become available to purchase with Alliance Healthcare as part of the new agreement. See below list of new products:

PIP                    Description

022-8338          PROCTOSEDYL SUPPS X12 GB

022-8312           PROCTSEDYL OINT 30G

095-3141            SOLPADOL 500 MG 100 CAPLETS

090-3708          SOLPADOL EFF TABS 100S

For your convenience, details of the Sanofi UK portfolio have been listed here.

Purchases of the Sanofi UK portfolio will arrive as part of your usual Alliance Healthcare delivery service and, if purchased in isolation they will not be subject to Alliance Healthcare’s low spend or fuel surcharges.

To receive the products from 01 November 2021, you can simply order from Alliance Healthcare in your usual manner. There will be no changes to the delivery service for Sanofi UK products through Alliance Healthcare.

If you would like to discuss these changes in more detail, please do not hesitate to contact your Alliance Healthcare Account Manager.

Alliance Healthcare (Distribution) Limited is selected as a partner with GSK Consumer Healthcare Ltd

We would like to inform you that today (1 October 2021) GSK Consumer Healthcare UK Ltd has chosen to partner with Alliance Healthcare (Distribution) Limited to optimise supply of its products and services to the Independent Pharmacy sector.

GSK Consumer Healthcare UK Ltd has now partnered with four national UK Pharmacy Wholesalers to supply all GSK consumer healthcare products to the Independent Pharmacy sector, hospitals and other healthcare outlets.

As a partner wholesaler to GSK,  Alliance Healthcare (Distribution) Limited are delighted to continue to promote GSK brands, offering support on ranging, merchandising, recommendation and key category insights via monthly promotional magazines and online platforms.

GSK Consumer Healthcare will continue its support to Community Pharmacies via the GSK Field and Telesales teams using the following assets:

•         Transfer Orders

•         Point of Sale activation

•         Staff Training & Education Resources

•         Digital Assets

•         Seasonal Promotional Offers (via Wholesaler of their choice).

There are no changes to the current GSK Consumer Healthcare portfolio. For your convenience, details of the GSK Consumer Healthcare portfolio have been provided here.

Purchases of the GSK Consumer Healthcare portfolio will arrive as part of your usual Alliance Healthcare delivery service and, if purchased in isolation they will not be subject to Alliance Healthcare’s low spend or fuel surcharges.

To receive the products from 01 October 2021, you can simply order from Alliance Healthcare in your usual manner. There will be no changes to the delivery service for the GSK Consumer Healthcare product portfolio through Alliance Healthcare.

If you would like to discuss these changes in more detail, please do not hesitate to contact your Alliance Healthcare Account Manager.

GSK Consumer Healthcare – RWA Agreement

From 01 October 2021, Alliance Healthcare UK has been chosen as one of four national UK Pharmacy Wholesalers to supply all GSK consumer healthcare products to the independent pharmacy sector, hospitals and other healthcare outlets.

If you have any queries, please speak to your Alliance Healthcare Account Manager.

Fontus Health – Solus Agreement

From 4th October 2021, Alliance Healthcare UK will become the only wholesaler to supply the Fontus Health product portfolio to all pharmacies and dispensing doctors in the United Kingdom.

If you have any queries, please speak to your Alliance Healthcare Account Manager.

Lupin Healthcare – Dual AAH Agreement

As of 24 August 2021, Alliance Healthcare UK became one of the chosen wholesalers to supply Lupin Healthcare’s new product Luforbec (Beclometasone 100mcg/Formoterol 6mcg inhaler CFC free) to all pharmacies and dispensing doctors in the United Kingdom.

If you have any queries, please speak to your Alliance Healthcare Account Manager.

Rosemont Pharmaceuticals – Dual Phoenix Agreement

From 1st August 2021, Alliance Healthcare UK will become one of the chosen wholesalers to supply selected products of Rosemont Pharmaceutical to all pharmacies and dispensing doctors in the United Kingdom. The other wholesaler in this agreement is Phoenix.

If you have any queries, please speak to your Alliance Healthcare Account Manager.